US 10689443
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10689443 (Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer) held by PRECISION BIOLOGICS, INC. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P